Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.58
-1.29 (-18.78%)
At close: Dec 5, 2025, 4:00 PM EST
5.73
+0.15 (2.69%)
After-hours: Dec 5, 2025, 5:25 PM EST
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $215.32 million as of December 5, 2025. Its market cap has increased by 351.83% in one year.
Market Cap
215.32M
Enterprise Value
85.35M
1-Year Change
351.83%
Ranking
Category
Stock Price
$5.58
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $215.32M, an increase of 24.35%. That is a compound annual growth rate of 3.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 265.09M | 4.58% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | 271.44M | 56.76% |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 930.92B |
| Johnson & Johnson | 494.65B |
| AbbVie | 406.09B |
| UnitedHealth Group | 306.76B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 254.80B |
| Thermo Fisher Scientific | 220.29B |